Investments
137Portfolio Exits
66Funds
6Service Providers
1Research containing Redmile Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Redmile Group in 1 CB Insights research brief, most recently on Jul 10, 2019.
Latest Redmile Group News
Apr 30, 2022
Asia-Pacific’s medical devices industry saw a rise of 4.76% in deal activity during March 2022, when compared with the last 12-month average, led by Fidelity Management & Research, Redmile Group and T Rowe Price Associates’ $125m private equity deal with Saluda Medical, according to GlobalData’s deals database. Embed this chart Embed this chart into your … The post Asia-Pacific’s medical devices industry saw a rise of 4.76% in deal activity during March 2022 appeared first on Medical Device Network.
Redmile Group Investments
137 Investments
Redmile Group has made 137 investments. Their latest investment was in Neuron23 as part of their Series C on March 3, 2022.
Redmile Group Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
3/30/2022 | Series C | Neuron23 | $100M | No | 2 | |
3/2/2022 | Series F | Saluda Medical | $125M | No | 4 | |
2/16/2022 | Series A | Star Therapeutics | $100M | Yes | 2 | |
2/16/2022 | Series B | |||||
11/9/2021 | Seed VC |
Date | 3/30/2022 | 3/2/2022 | 2/16/2022 | 2/16/2022 | 11/9/2021 |
|---|---|---|---|---|---|
Round | Series C | Series F | Series A | Series B | Seed VC |
Company | Neuron23 | Saluda Medical | Star Therapeutics | ||
Amount | $100M | $125M | $100M | ||
New? | No | No | Yes | ||
Co-Investors | |||||
Sources | 2 | 4 | 2 |
Redmile Group Portfolio Exits
66 Portfolio Exits
Redmile Group has 66 portfolio exits. Their latest portfolio exit was Amunix on December 21, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
12/21/2021 | Acquired | 10 | |||
10/29/2021 | IPO | Public | 4 | ||
10/29/2021 | IPO | Public | 7 | ||
Date | 12/21/2021 | 10/29/2021 | 10/29/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | IPO | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 10 | 4 | 7 |
Redmile Group Fund History
6 Fund Histories
Redmile Group has 6 funds, including RedCo I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
5/26/2020 | RedCo I | $187.49M | 1 | ||
3/5/2020 | Redmile Biopharma Investments II | ||||
7/27/2018 | Redmile Biopharma Investments I | ||||
12/30/2015 | Redmile Private Investments II | ||||
Redmile Biopharma Investments III |
Closing Date | 5/26/2020 | 3/5/2020 | 7/27/2018 | 12/30/2015 | |
|---|---|---|---|---|---|
Fund | RedCo I | Redmile Biopharma Investments II | Redmile Biopharma Investments I | Redmile Private Investments II | Redmile Biopharma Investments III |
Fund Type | |||||
Status | |||||
Amount | $187.49M | ||||
Sources | 1 |
Redmile Group Service Providers
1 Service Provider
Redmile Group has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
PIPE | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | PIPE |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
Redmile Group Team
8 Team Members
Redmile Group has 8 team members, including current Chief Financial Officer, Joshua Garcia.
Name | Work History | Title | Status |
|---|---|---|---|
Joshua Garcia | Chief Financial Officer | Current | |
Bryan R Crapo | Chief Operating Officer | Current | |
Travis Breznak | Controller | Current | |
Ming Fang | Managing Director | Current | |
Rob Faulkner | Managing Director | Current |
Name | Joshua Garcia | Bryan R Crapo | Travis Breznak | Ming Fang | Rob Faulkner |
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Financial Officer | Chief Operating Officer | Controller | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.